Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anterix (ATEX) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Anterix (ATEX) over the last 13 years, with Q4 2025 value amounting to 576.03%.

  • Anterix's EBITDA Margin fell 10250800.0% to 576.03% in Q4 2025 from the same period last year, while for Dec 2025 it was 1407.47%, marking a year-over-year increase of 19432400.0%. This contributed to the annual value of 185.94% for FY2025, which is 364900.0% up from last year.
  • Latest data reveals that Anterix reported EBITDA Margin of 576.03% as of Q4 2025, which was down 10250800.0% from 3909.47% recorded in Q3 2025.
  • Anterix's EBITDA Margin's 5-year high stood at 3909.47% during Q3 2025, with a 5-year trough of 6572.53% in Q2 2021.
  • In the last 5 years, Anterix's EBITDA Margin had a median value of 840.38% in 2024 and averaged 1119.9%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 58032000bps in 2023, then tumbled by -34123300bps in 2024.
  • Anterix's EBITDA Margin (Quarter) stood at 3214.29% in 2021, then surged by 55bps to 1453.98% in 2022, then surged by 105bps to 76.24% in 2023, then skyrocketed by 489bps to 449.04% in 2024, then tumbled by -228bps to 576.03% in 2025.
  • Its last three reported values are 576.03% in Q4 2025, 3909.47% for Q3 2025, and 1585.4% during Q2 2025.